A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, Keiji, Imai, Yumiko, Rao, Shuan, Gao, Hong, Guo, Feng, Guan, Bin, Huan, Yi, Yang, Peng +16 more·2005·Nature Medicine
DOI 10.1038/nm1267

Cited by (1,008)

Items 801–900 of 1,008

  1. Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
    Kuo‐Yen Huang, Ming‐Shiu Lin, Ting‐Chun Kuo, Ci‐Ling Chen, Chung‐Chih Lin, Yu‐Chi Chou, Tai‐Ling Chao, Yu-Hao Pang, Han‐Chieh Kao, Rih‐Sheng Huang et al. · 2020 · EMBO Molecular Medicine
  2. COVID-19 and cardiovascular diseases
    Fan Liu, Feng Liu, Lu Wang · 2020 · Journal of Molecular Cell Biology
  3. Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
    Jyoti Chhibber‐Goel, Sreehari Gopinathan, Amit Kumar Sharma · 2021 · Gut Pathogens
  4. Sex Hormones and Lung Inflammation
    Jorge Reyes-García, Luis M. Montaño, Abril Carbajal-García, Yong-Xiao Wang · 2021 · Advances in experimental medicine and biology
  5. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
    Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, Débora Regina Daga, Patrícia Shigunov, Marco Augusto Stimamiglio, Daniela Boscaro Marsaro, Bruna Schaidt, Andressa Micosky, Ana Paula de Azambuja et al. · 2022 · Stem Cell Research & Therapy
  6. Pathogen-sugar interactions revealed by universal saturation transfer analysis
    Charles J. Buchanan, Ben Gaunt, Peter J. Harrison, Yun Yang, Jiwei Liu, Aziz Khan, Andrew M. Giltrap, Audrey Le Bas, Philip N. Ward, Kapil Gupta et al. · 2022 · Science
  7. LPS-Stimulated Cytokine Production in Type I Cells Is Modulated by the Renin–Angiotensin System
    Mandi H. Wong, Olivia C. Chapin, Meshell D. Johnson · 2011 · American Journal of Respiratory Cell and Molecular Biology
  8. Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study
    Shih-Yi Lin, Cheng‐Li Lin, Cheng‐Chieh Lin, Wu‐Huei Hsu, Chia-Der Lin, I‐Kuan Wang, Chung Y. Hsu, Chia‐Hung Kao · 2020 · Cancers
  9. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses
    Flavia Giannessi, Alessandra Aiello, Francesca Franchi, Zulema Antonia Percario, Elisabetta Affabris · 2020 · Viruses
  10. Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response
    Ali Châari, Ghizlane Bendriss, Dalia Zakaria, Clare McVeigh · 2020 · Frontiers in Public Health
  11. How the SARS coronavirus causes disease: host or organism?
    Anthony W.I. Lo, Nelson L.S. Tang, Ka‐Fai To · 2005 · The Journal of Pathology
  12. Upregulation of Mitochondrial Gene Expression in PBMC from Convalescent SARS Patients
    HONGWEI SHAO, Dongming Lan, Zhaohui Duan, Zehuan Liu, JUN MIN, Lichun Zhang, Jian Huang, Jing Su, Shangwu Chen, Anlong Xu · 2006 · Journal of Clinical Immunology
  13. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response
    Ignacio Ortea, Jens-Ole Bock · 2020 · Aging
  14. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities
    James Jiqi Wang, Matthew L. Edin, Darryl C. Zeldin, Chenze Li, Dao Wen Wang, Chen Chen · 2020 · Pharmacology & Therapeutics
  15. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
    Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, Massimiliano Galdiero, Claudio Napoli A · 2020 · British Journal of Anaesthesia
  16. Glucocorticoid excess and COVID-19 disease
    Valentina Guarnotta, Rosario Ferrigno, Marianna Martino, Mattia Barbot, Andrea Maria Isidori, Carla Maria Scaroni, Angelo Ferrante, Giorgio Arnaldi, Rosario Pivonello, Carla Santos de Souza Giordano · 2020 · Reviews in Endocrine and Metabolic Disorders
  17. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection
    Fulton A. Robinson, Ryan P Mihealsick, Brant M. Wagener, Peter Hanna, Megan D. Poston, Igor R. Efimov, Kalyanam Shivkumar, Donald B. Hoover · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  18. Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review
    Badriyah Alhalaili, Ileana Nicoleta Popescu, Olfa Kamoun, Feras Alzubi, Sami Alawadhia, Ruxandra Vidu · 2020 · Sensors
  19. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
    Murat Öz, Dietrich Ernst Lorke · 2021 · Biomedicine & Pharmacotherapy
  20. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
    George Lagoumintzis, Christos T. Chasapis, N. Alexandris, D. Kouretas, S. Tzartos, E. Eliopoulos, K. Farsalinos, K. Poulas · 2021 · Food and Chemical Toxicology
  21. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review
    WY Lee, Annie Lai Fong Mok, Jacqueline Pui Wah Chung · 2021 · Hong Kong Medical Journal
  22. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development
    Medha Karnik, Narasimha Murthy Beeraka, Chinnappa A. Uthaiah, Suma Maduvanahalli Nataraj, Anjali Devi S. Bettadapura, Gjumrakch M. Aliev, SubbaRao V. Madhunapantula · 2021 · Molecular Neurobiology
  23. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
    Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Émilie Delattre et al. · 2021 · Frontiers in Public Health
  24. Potential Effects of Coronaviruses on the Liver: An Update
    Xinyi Wang, Jianyong Lei, Zhihui Li, Lünan Yan · 2021 · Frontiers in Medicine
  25. Acute Respiratory Distress Syndrome and COVID-19: A Literature Review
    Musaddique Hussain, Shahzada Khurram Syed, Mobeen Fatima, Saira Shaukat, Malik Saadullah, Ali Alqahtani, Taha Alqahtani, Talha Bin Emran, Ali H. Alamri, Muhammad Qasim Barkat et al. · 2021 · Journal of Inflammation Research
  26. Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or Maladaptive
    Madathilparambil V. Suresh, Sanjay Balijepalli, Sumeet A. Solanki, Sinan L Aktay, Khushi Choudhary, Yatrik Madhukar Shah, Krishnan Raghavendran · 2023 · Inflammation
  27. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
    Teruki Sato, Ayumi Kadowaki, Takashi A. SUZUKI, Hiroshi Ito, Hiroyuki Watanabe, Yumiko Imai, Keiji Kuba · 2019 · International Journal of Molecular Sciences
  28. The ACE2‐deficient mouse: A model for a cytokine storm‐driven inflammation
    Junyi Wang, Nihal Kaplan, Jan A Wysocki, Wending Yang, Kurt Q. Lu, Han Peng, DANIEL C. BATLLE, Robert M. Lavker · 2020 · The FASEB Journal
  29. Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
    Stephen B Milne, Xuan Li, Chen Xi Yang, Ana I. Hernández Cordero, Fernando Sergio Leitao Filho, Cheng Wei Tony Yang, Tawimas Shaipanich, Stephan F. van Eeden, Janice M. Leung, Stephen C. Lam et al. · 2021 · European Respiratory Journal
  30. Angiotensin converting enzyme-2 as therapeutic target in COVID-19
    Neda Roshanravan, Samad Ghaffari, Mehdi Hedayati · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  31. Maternal and neonatal response to COVID-19
    Thea Golden, Rebecca Anne Simmons · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  32. Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
    Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Phongthon Kanjanasirirat, Priyo Budi Purwono, Kaewta Rattanapisit, Balamurugan Shanmugaraj, Duncan Richard Smith, Suparerk Borwornpinyo, Arunee Thitithanyanont, Waranyoo Phoolcharoen · 2021 · Frontiers in Plant Science
  33. Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19
    Eli Mansour, André C. Palma, Raisa Gusso Ulaf, Luciana C. Ribeiro, Ana Flávia Bernardes, Thyago A. Nunes, Marcus Vinicius Rodrigues de Agrela, Bruna Bombassaro, Milena Monfort‐Pires, Rafael Ludemann Camargo et al. · 2021 · Viruses
  34. Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
    Hui Lin, Frank Geurts, Luise Hassler, DANIEL C. BATLLE, Katrina M. Mirabito Colafella, Kate M. Denton, Jia L. Zhuo, Xiao C. Li, Nirupama Ramkumar, Masahiro Koizumi et al. · 2022 · Pharmacological Reviews
  35. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
    Shuliang Chen, Xiao Yu, Deyin Guo · 2018 · Viruses
  36. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
    Jixiang Zhang, Shimin Lu, Xiaoli Wang, Xuemei Jia, Jiao Li, Hongbo Lei, Zhengru Liu, Fei Liao, Mengyao Ji, Xiaoguang Lv et al. · 2020 · Heart
  37. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
    Rosemary Gan, Nicholas Rosoman, David J.E. Henshaw, Euan P Noble, Peter Georgius, Nigel Sommerfeld · 2020 · Medical Hypotheses
  38. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
    Gianluca Trifirò, Marco Massari, Roberto Da Cas, Francesca Menniti‐Ippolito, Janet Sultana, Salvatore Crisafulli, Paolo Giorgi Rossi, Massimiliano Marino, Manuel Zorzi, Emanuela Bovo et al. · 2020 · Drug Safety
  39. The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons
    José Luis Labandeira-García, Rita Valenzuela, Maria A. Costa-Besada, Begoña Villar‐Cheda, Ana Isabel Rodriguez-Perez · 2020 · Progress in Neurobiology
  40. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
    Xiao Jiang, James Eales, David Scannali, Alicja Nazgiewicz, Priscilla Ribeiro Prestes, Michelle Carla Maier, Matthew J. Denniff, Xiaoguang Xu, Sushant Saluja, Eddie Cano-Gamez et al. · 2020 · European Heart Journal
  41. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
    Mohamed Fizur Nagoor Meeran, Hayate Javed, Charu Sharma, Sameer N. Goyal, Sanjay Kumar, Niraj Kumar Jha, Shreesh Kumar Ojha · 2021 · Heliyon
  42. CD38 in the age of COVID-19: a medical perspective
    A. Horenstein, A. Faini, F. Malavasi · 2021 · Physiological Reviews
  43. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
    Robin Augustine, Abhilash S, Ajisha Nayeem, Shaheen Abdul Salam, Priya Augustine, Pan Dan, Pablo Maureira, Fatima Mraiche, Carmine Gentile, Philip M. Hansbro et al. · 2021 · Chemico-Biological Interactions
  44. ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19
    Nathaniel L. Lartey, Salvador Valle-Reyes, Hilda Vargas-Robles, Karina E Jiménez-Camacho, Idaira M Guerrero-Fonseca, Ramón Castellanos-Martínez, Armando Montoya-García, Julio García-Cordero, Leticia Cedillo-Barrón, Porfirio Nava et al. · 2021 · Journal of Leukocyte Biology
  45. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  46. The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
    Claire Lugnier · 2022 · International Journal of Molecular Sciences
  47. Human Coronaviruses 229E and NL63: Close Yet Still So Far
    Ronald Dijkman, Lia van der Hoek · 2009 · Journal of the Formosan Medical Association
  48. Emergence of the Middle East Respiratory Syndrome Coronavirus
    Christopher M. Coleman, Matthew B. Frieman · 2013 · PLoS Pathogens
  49. Elevated Blood Pressure Increases Pneumonia Risk: Epidemiological Association and Mendelian Randomization in the UK Biobank
    Seyedeh Maryam Zekavat, Michael C. Honigberg, James P. Pirruccello, Puja Kohli, Elizabeth W. Karlson, Christopher Newton‐Cheh, Hongyu Zhao, Pradeep Natarajan · 2020 · Med
  50. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
    Rui Rodrigues, Sofia Costa‐de‐Oliveira · 2021 · Microorganisms
  51. Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
    Domenico Acanfora, Marco Matteo Ciccone, Pietro Scicchitano, Chiara Acanfora, Gerardo Casucci · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  52. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae
    Hau C. Kwaan · 2020 · Seminars in Thrombosis and Hemostasis
  53. Cardiovascular disease and COVID-19: les liaisons dangereuses
    Andrea Barison, Alberto Aimo, Vincenzo Castiglione, Chiara Arzilli, Josep Lupón, Pau Codina, Evelyn Santiago‐Vacas, Germán Cediel, Michele Emdin, Antoni Bayés‐Genís · 2020 · European Journal of Preventive Cardiology
  54. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini · 2020 · Vaccines
  55. Role and mechanism of angiotensin‐converting enzyme 2 in acute lung injury in coronavirus disease 2019
    Meng‐Yuan Liu, Bo Jian Zheng, Yan Zhang, Jianping Li · 2020 · Chronic Diseases and Translational Medicine
  56. COVID-19-Associated Myocarditis in an Adolescent
    Brit Trogen, Francisco J. Gonzalez, Gail F. Shust · 2020 · The Pediatric Infectious Disease Journal
  57. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?
    José Luis Quiles, Lorenzo Rivas‐García, Alfonso Varela‐López, Juan Llopis, Maurizio Antonio Battino, Cristina Sánchez‐González · 2020 · Environmental Research
  58. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study
    Matsuzawa, Yasushi, Ogawa, Hisao, Kimura, Kazuo, Konishi, Masaaki, Kirigaya, Jin, Fukui, Kazuki, Tsukahara, Kengo, Shimizu, Hiroyuki, Iwabuchi, Keisuke, Yamada, Yu et al. · 2020 · Hypertension Research
  59. Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
    Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra · 2020 · Frontiers in Pharmacology
  60. COVID-19 during Pregnancy and Postpartum:
    Sreus A. G. Naidu, Roger Clemens, Peter Pressman, Mehreen Zaigham, Kamran Kadkhoda, Kelvin J.A. Davies, A. Satyanarayan Naidu · 2020 · Journal of Dietary Supplements
  61. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
    Seyed Mohammad Ali Hashemi, Marijn Thijssen, Seyed Younes Hosseini, Alijan Tabarraei, Mahmoud Reza Pourkarim, Jamal Sarvari · 2021 · Archives of Virology
  62. COVID‐19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives
    Luca Esposito, Francesco Paolo Cancro, Angelo Silverio, Marco Di Maio, Patrizia Iannece, Antonio Damato, Carmine Alfano, Giuseppe De Luca, Carmine Vecchione, Gennaro Galasso · 2021 · Oxidative Medicine and Cellular Longevity
  63. Tanshinone IIA Attenuates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/ Angiotensin-(1-7) Axis in Rats
    Huajie Wu, Yan Li, Yanxia Wang, Dun-Quan Xu, Congcong Li, Manling Liu, Xin Sun, Zhichao Li · 2014 · International Journal of Medical Sciences
  64. Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity
    Liliya M. Yamaleyeva, Víctor M. Pulgar, Sarah Hoffmann Lindsey, Larissa Yamane, Jasmina Varagić, Carolynne M. McGee, Mauro S. B. Silva, Paula Lopes Bonfa, Susan B. Gurley, K. Bridget Brosnihan · 2015 · American Journal of Physiology-Endocrinology and Metabolism
  65. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases
    Faxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei‐Fen Xie, Xiang Wang, Yuanliang Xie · 2020 · Annals of Hepatology
  66. Immunogenetic Predictors of Severe COVID-19
    Anna M. Malkova, Dmitry Anatolievich Kudlay, Igor Vladimirovich Kudryavtsev, Anna Andreevna Starshinova, P. K. Yаblonskiy, Yehuda Shoenfeld · 2021 · Vaccines
  67. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
    Zena Wehbe, Safaa H. Hammoud, Hadi Mohamad Yassine, Manal Fardoun, Ahmed Fawzy EL‐Yazbi, Ali Hussein Eid · 2021 · Frontiers in Immunology
  68. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
    Teding Chang, Jingzhi Yang, Hai Deng, Deng Chen, Xiang‐Ping Yang, Zhaohui Tang · 2022 · Frontiers in Immunology
  69. Renin-angiotensin system in human coronavirus pathogenesis
    Wevers, Brigitte A, Hoek, Lia van der · 2010 · Future Virology
  70. Membrane ectopeptidases targeted by human coronaviruses
    Berend‐Jan Bosch, Saskia L. Smits, Bart L. Haagmans · 2014 · Current Opinion in Virology
  71. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin–angiotensin system
    Annette K. Offringa, Roy C. Montijn, Sandeep Singh, M. Paul, Yigal M. Pinto, Sara‐Joan Pinto‐Sietsma · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  72. Chronic ACE Inhibitor use is Associated with Decreased Odds of Severe Disease in Patients with COVID-19
    Rasimcan Meral · 2020 · The Anatolian Journal of Cardiology
  73. The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
    Hau C. Kwaan, Paul F. Lindholm · 2021 · International Journal of Molecular Sciences
  74. The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection
    Susan Wray, Sarah Arrowsmith · 2021 · Frontiers in Physiology
  75. Hypertension in Patients Hospitalized with COVID-19 in Wuhan, China
    Zhenhua Zeng, Tong Sha, Yuan Zhang, Hongbin Hu, Hongbin Hu, Haijun Li, Jiafa Han, Wenhong Song, Qiaobing Huang, Zhongqing Chen · 2021 · International Heart Journal
  76. Sex hormones, autoimmunity and gender disparity in COVID-19
    Hussain Ahmed Raza, Parikshit Sen, Omaima Anis Bhatti, Latika Gupta · 2021 · Rheumatology International
  77. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
  78. An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2
    Lianghui Zhang, Krishna K. Narayanan, Laura M. Cooper, Kui K. Chan, Savanna S. Skeeters, Christine A. Devlin, Aaron Aguhob, Kristie M. Shirley, Lijun Rong, Jalees Rehman et al. · 2022 · EMBO Molecular Medicine
  79. Lung fibrosis: Post-COVID-19 complications and evidences
    Rishabh Hirawat, Namrata Jain, Mohd Aslam Saifi, Mahesh Rachamalla, Chandraiah Godugu · 2022 · International Immunopharmacology
  80. Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2
    Yun Shi, Bo Zhang, Xiangjun Chen, Dun-Quan Xu, Yanxia Wang, Haiying Dong, Shi-Rong Ma, Ri-He Sun, Yanping Hui, Zhichao Li · 2013 · European Journal of Pharmaceutical Sciences
  81. SARS-CoV-2 (COVID-19) and cystic fibrosis
    Bruce A. Stanton, Thomas H. Hampton, Alix Ashare · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  82. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
    Natasja G. de Groot, Ronald E. Bontrop · 2020 · Immunogenetics
  83. SARS-CoV-2 (COVID-19) and the Endocrine System
    Michelle Diane Lundholm, Caroline A Poku, Nicholas Emanuele, Mary Ann Emanuele, Norma Lopez · 2020 · Journal of the Endocrine Society
  84. COVID-19: Direct and Indirect Mechanisms of Statins
    Agnieszka Pawlos, Mateusz Niedzielski, Paulina Gorzelak‐Pabiś, Marlena Broncel, Ewelina Woźniak · 2021 · International Journal of Molecular Sciences
  85. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
    Mehdi Shahgolzari, Afagh Yavari, Yaser Arjeini, Seyed Mohammad Miri, Amirhossein Darabi, Amir Sasan Mozaffari Nejad, Mohsen Keshavarz · 2021 · Gene Reports
  86. Prevalence and patterns of symptoms of dysautonomia in patients with long‐ COVID syndrome: A cross‐sectional study
    Ahmed El‐Dokla, Aliae A. Mohamed‐Hussein, Ahmed Fouad, Mariam G. Abdelnasser, Sara T. Ali, Nahed Ahmed Makhlouf, Islam Galal Sayed, Hoda Ahmed Makhlouf, Jaffer Shah, Hani Aiash · 2022 · Annals of Clinical and Translational Neurology
  87. Gastrointestinal Involvement in SARS-CoV-2 Infection
    Tsung‐Hsien Chen, Ming‐Tse Hsu, Ming‐Yang Lee, Chu‐Kuang Chou · 2022 · Viruses
  88. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report
    Henry, Brandon Michael, Benoit, Stefanie, Lippi, Giuseppe, Benoit, Justin · 2020 · Progress in Cardiovascular Diseases
  89. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
    Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren · 2020 · Frontiers in Medicine
  90. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach
    Sahar Najafi, Elham Rajaei, Rezvan Moallemian, Forough Nokhostin · 2020 · Clinical Rheumatology
  91. Food science and COVID-19
    Klaus W. Lange · 2020 · Food Science and Human Wellness
  92. Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
    Mahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi · 2021 · Molecular Neurobiology
  93. AI-guided discovery of the invariant host response to viral pandemics
    Debashis Sahoo, Gajanan Dattatray Katkar, Soni Khandelwal, Mahdi Behroozikhah, Amanraj Claire, Vanessa Castillo, Courtney Tindle, Mackenzie Fuller, Sahar Taheri, Thomas F. Rogers et al. · 2021 · EBioMedicine
  94. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
    Azita H. Talasaz, Hessam Kakavand, Benjamin W. Van Tassell, Maryam Aghakouchakzadeh, Parham Sadeghipour, Steven P. Dunn, Babak Geraiely · 2020 · Cardiovascular Drugs and Therapy
  95. Naturally Occurring Animal Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease
    Scott P. Kenney, Qiuhong Wang, Anastasia Nickolaevna Vlasova, Kwonil Jung, Linda J. Saif · 2020 · Veterinary Pathology
  96. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin
    Samuel K. Kwofie, Emmanuel Broni, Seth O. Asiedu, Gabriel B. Kwarko, Bismark Dankwa, Kweku S. Enninful, Elvis Kwason Tiburu, Michael D. Wilson · 2021 · Molecules
  97. SARS-CoV-2 and the reproductive system: known and the unknown..!!
    Indu Sharma, Priti Kumari, Anuradha Sharma, Subhas Chandra Saha · 2021 · Middle East Fertility Society Journal
  98. Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
    Yaqing Wang, Peng Wang, Jianhua Qin · 2022 · Advanced Science
  99. COVID-19 and the cardiovascular system: an update
    Joshua Kuimeta Salabei, Zekarias T. Asnake, Zeeshan H. Ismail, Kipson Charles, Greg Stanger, Abdullah H. Abdullahi, Andrew T Abraham, Peters Okonoboh · 2022 · The American Journal of the Medical Sciences
  100. SARS-CoV-2 Infection and the Newborn
    Fahri Ovalı · 2020 · Frontiers in Pediatrics